IRCT20140818018842N35招募中1 期
Prophylactic administration of Natural Killer cells early after hematopoietic stem cell transplantation in adult patients with high-risk acute myeloid leukemia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Age 18 years old or more
- •Recipients of allogeneic Stem Cell Transplantation for high-risk Acute Myeloid Leukemia by ELN classification
- •Recipients of allogeneic Stem Cell Transplantation from matched or mismatched donors.
- •MRD = 5% after the first Induction or MRD = 0.1% after the second Induction or MRD = 0.01% before transplantation
- •Normal organ function
排除标准
- •Second allogeneic Stem Cell Transplantation
- •Active or uncontrolled infection
- •Acute graft versus host disease
研究者
相似试验
招募中
Unknown
Cell therapy using natural killer cells pretreatment with Anti-NKG2A in patients with hepatocellular carcinomaIRCT20140818018842N41Tehran University of Medical Sciences3
招募中
2 期
Prophylactic infusion of NK cell and gamma/delta chain positive T cell from transplantation donor for poor prognostic or refractory hematologic malignancy and solid tumor -Ibaraki Children's Hospital phase II studyJPRN-UMIN000028370Ibaraki Children's Hospital10
尚未招募
不适用
atural Killer cel therapie tegen teruggekeerde eierstokkanker.Recurrent ovarian carcinoma, recidief ovarium carcinoom. immunotherapy, immuuntherapie.NL-OMON20648Radboudumc12
进行中（未招募）
1 期
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with Non-Small Cell Lung Cancer (NSCLC) after radiochemotherapy (RCT)EUCTR2008-002130-30-DETechnische Universität München Fakultät für Medizin90
招募中
1 期
atural killer cell therapy in acute myeloid leukemia patients patientsAcute myeloid leukemia.Acute myeloblastic leukaemiaC92.0IRCT20230801058996N2Shahid Beheshti University of Medical Sciences15